ARK Genomic Revolution ETF (BATS:ARKG) Reaches New 52-Week High – Here’s Why

ARK Genomic Revolution ETF (BATS:ARKG) hit a new 52-week high on Thursday . The company traded as high as $51.32 and last traded at $51.9010, with a volume of 2825670 shares trading hands. The stock had previously closed at $47.85.

ARK Genomic Revolution ETF Price Performance

The company has a 50-day moving average of $43.68 and a 200-day moving average of $35.75.

Institutional Trading of ARK Genomic Revolution ETF

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC acquired a new stake in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at approximately $104,000. Baird Financial Group Inc. boosted its position in ARK Genomic Revolution ETF by 0.3% during the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock worth $3,101,000 after acquiring an additional 255 shares during the last quarter. Waverly Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter worth approximately $255,000. Turner Financial Group Inc. acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter valued at $1,633,000. Finally, Continuum Advisory LLC purchased a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter worth $76,000.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.